title: Physiologic Concepts That May Revise the Interpretation and Implications of HbA1C in Clinical Medicine: An American Perspective.
abstract: HbA1c, a routinely used integrated measure of glycemic control, is traditionally thought to be equivalent to mean blood glucose in hematologically normal individuals. Therefore, particularly as the methodology of measuring HbA1c has been standardized, clinical decisions dependent on mean blood glucose are often predominantly decided based on the interpretation of measured HbA1c. In this commentary, however, now that a more routine method of measuring red cell life span has been developed, we present evidence that the relationship between HbA1c and mean blood glucose is influenced by variation in red blood cell survival even in the hematologically normal. This variation has consequences for the appropriate interpretation of HbA1c in diverse clinical conditions such as the diagnosis of diabetes and management of diabetes in chronic kidney disease.
authors.affiliation: Department of Medicine, Division of Endocrinology, Diabetes & Metabolism, University of Cincinnati College of Medicine and Cincinnati VA Medical Center, Cincinnati, OH, USA.
authors.forename: Eric P
authors.initials: EP
authors.lastname: Smith
authors.affiliation: Department of Medicine, Division of Endocrinology, Diabetes & Metabolism, University of Cincinnati College of Medicine and Cincinnati VA Medical Center, Cincinnati, OH, USA robert.cohen@uc.edu.
authors.forename: Robert M
authors.initials: RM
authors.lastname: Cohen
mesh_terms: D015415:Biomarkers; D003920:Diabetes Mellitus / Q000097:blood* / Q000175:diagnosis* / Q000628:therapy; D006442:Glycated Hemoglobin / Q000032:analysis / Q000378:metabolism*; D006801:Humans; D011237:Predictive Value of Tests; D012015:Reference Standards; D014481:United States
chemical_list: D015415:Biomarkers; D006442:Glycated Hemoglobin
keywords: HbA1c; chronic kidney disease; diabetes diagosis; red cell life span